Identification of a Novel Bone Marrow Cell‐Derived Accelerator of Fibrotic Liver Regeneration Through Mobilization of Hepatic Progenitor Cells in Mice
Granulocyte colony stimulating factor (G‐CSF) has been reported to ameliorate impaired liver function in patients with advanced liver diseases through mobilization and proliferation of hepatic progenitor cells (HPCs). However, the underlying mechanisms remain unknown. We previously showed that G‐CSF...
Gespeichert in:
Veröffentlicht in: | Stem cells (Dayton, Ohio) Ohio), 2019-01, Vol.37 (1), p.89-101 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 101 |
---|---|
container_issue | 1 |
container_start_page | 89 |
container_title | Stem cells (Dayton, Ohio) |
container_volume | 37 |
creator | Yanagawa, Takayo Sumiyoshi, Hideaki Higashi, Kiyoshi Nakao, Sachie Higashiyama, Reiichi Fukumitsu, Hiroshi Minakawa, Kaori Chiba, Yosuke Suzuki, Yuhei Sumida, Kayo Saito, Koichi Kamiya, Akihide Inagaki, Yutaka |
description | Granulocyte colony stimulating factor (G‐CSF) has been reported to ameliorate impaired liver function in patients with advanced liver diseases through mobilization and proliferation of hepatic progenitor cells (HPCs). However, the underlying mechanisms remain unknown. We previously showed that G‐CSF treatment increased the number of bone marrow (BM)‐derived cells migrating to the fibrotic liver following repeated carbon tetrachloride (CCl4) injections into mice. In this study, we identified opioid growth factor receptor‐like 1 (OGFRL1) as a novel BM cell‐derived accelerator of fibrotic liver regeneration in response to G‐CSF treatment. Endogenous Ogfrl1 was highly expressed in the hematopoietic organs such as the BM and spleen, whereas the liver contained a relatively small amount of Ogfrl1 mRNA. Among the peripheral blood cells, monocytes were the major sources of OGFRL1. Endogenous Ogfrl1 expression in both the peripheral blood monocytes and the liver was decreased following repeated CCl4 injections. An intrasplenic injection of cells overexpressing OGFRL1 into CCl4‐treated fibrotic mice increased the number of HPC and stimulated proliferation of hepatic parenchymal cells after partial resection of the fibrotic liver. Furthermore, overexpression of OGFRL1 in cultured HPC accelerated their differentiation as estimated by increased expression of liver‐specific genes such as hepatocyte nuclear factor 4α, cytochrome P450, and fatty acid binding protein 1, although it did not affect the colony forming ability of HPC. These results indicate a critical role of OGFRL1 in the mobilization and differentiation of HPC in the fibrotic liver, and administration of OGFRL1‐expressing cells may serve as a potential regenerative therapy for advanced liver fibrosis. Stem Cells 2019;37:89–101
Intrasplenic administration of bone marrow mesenchymal stem cells (MSC) overexpressing opioid growth factor receptor‐like 1 into carbon tetrachloride (CCl4)‐induced fibrotic mice increased the number of α‐fetoprotein (AFP)‐positive cells with active bromodeoxyuridine (BrdU) uptake and that of proliferating parenchymal hepatocytes following 70% partial resection of the fibrotic liver. |
doi_str_mv | 10.1002/stem.2916 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2115275542</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2161869058</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4546-acdeb49cfcb1b551c018c2f78172d6e899c9d6fbfffaa63b3f3f5082c1577c7c3</originalsourceid><addsrcrecordid>eNp1kc9u1DAQhy1U1H_0wAsgS73QQ1rbiR37WJaWVtotCJZz5Djj1lU2XuykVTnxCBx5Pp4Eu1t6QOI0I80339j6IfSakmNKCDuJI6yOmaLiBdqlvFJFpajcSj0RouBEqR20F-MtIbTiUm6jnZKwmlRS7qJflx0Mo7PO6NH5AXuLNb7yd9Djd34AvNAh-Hs8g77__ePnewjuDjp8agz0EPToQ944d23wozN4nqYBf4ZrGPI0C5c3wU_XN3jhW9e7789XLmCt88qn4BPtsikfidgNeOEMvEIvre4jHDzVffT1_Gw5uyjmHz9czk7nhal4JQptOmgrZaxpacs5NYRKw2wtac06AVIpozphW2ut1qJsS1taTiQzlNe1qU25j95uvOvgv00Qx2blYvpdrwfwU2wYpZzVnFcsoYf_oLd-CkN6XaIElUIRLhN1tKFM8DEGsM06uJUODw0lTY6ryXE1Oa7EvnkyTu0Kumfybz4JONkA966Hh_-bmi_Ls8Wj8g9AKaK4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2161869058</pqid></control><display><type>article</type><title>Identification of a Novel Bone Marrow Cell‐Derived Accelerator of Fibrotic Liver Regeneration Through Mobilization of Hepatic Progenitor Cells in Mice</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Yanagawa, Takayo ; Sumiyoshi, Hideaki ; Higashi, Kiyoshi ; Nakao, Sachie ; Higashiyama, Reiichi ; Fukumitsu, Hiroshi ; Minakawa, Kaori ; Chiba, Yosuke ; Suzuki, Yuhei ; Sumida, Kayo ; Saito, Koichi ; Kamiya, Akihide ; Inagaki, Yutaka</creator><creatorcontrib>Yanagawa, Takayo ; Sumiyoshi, Hideaki ; Higashi, Kiyoshi ; Nakao, Sachie ; Higashiyama, Reiichi ; Fukumitsu, Hiroshi ; Minakawa, Kaori ; Chiba, Yosuke ; Suzuki, Yuhei ; Sumida, Kayo ; Saito, Koichi ; Kamiya, Akihide ; Inagaki, Yutaka</creatorcontrib><description>Granulocyte colony stimulating factor (G‐CSF) has been reported to ameliorate impaired liver function in patients with advanced liver diseases through mobilization and proliferation of hepatic progenitor cells (HPCs). However, the underlying mechanisms remain unknown. We previously showed that G‐CSF treatment increased the number of bone marrow (BM)‐derived cells migrating to the fibrotic liver following repeated carbon tetrachloride (CCl4) injections into mice. In this study, we identified opioid growth factor receptor‐like 1 (OGFRL1) as a novel BM cell‐derived accelerator of fibrotic liver regeneration in response to G‐CSF treatment. Endogenous Ogfrl1 was highly expressed in the hematopoietic organs such as the BM and spleen, whereas the liver contained a relatively small amount of Ogfrl1 mRNA. Among the peripheral blood cells, monocytes were the major sources of OGFRL1. Endogenous Ogfrl1 expression in both the peripheral blood monocytes and the liver was decreased following repeated CCl4 injections. An intrasplenic injection of cells overexpressing OGFRL1 into CCl4‐treated fibrotic mice increased the number of HPC and stimulated proliferation of hepatic parenchymal cells after partial resection of the fibrotic liver. Furthermore, overexpression of OGFRL1 in cultured HPC accelerated their differentiation as estimated by increased expression of liver‐specific genes such as hepatocyte nuclear factor 4α, cytochrome P450, and fatty acid binding protein 1, although it did not affect the colony forming ability of HPC. These results indicate a critical role of OGFRL1 in the mobilization and differentiation of HPC in the fibrotic liver, and administration of OGFRL1‐expressing cells may serve as a potential regenerative therapy for advanced liver fibrosis. Stem Cells 2019;37:89–101
Intrasplenic administration of bone marrow mesenchymal stem cells (MSC) overexpressing opioid growth factor receptor‐like 1 into carbon tetrachloride (CCl4)‐induced fibrotic mice increased the number of α‐fetoprotein (AFP)‐positive cells with active bromodeoxyuridine (BrdU) uptake and that of proliferating parenchymal hepatocytes following 70% partial resection of the fibrotic liver.</description><identifier>ISSN: 1066-5099</identifier><identifier>EISSN: 1549-4918</identifier><identifier>DOI: 10.1002/stem.2916</identifier><identifier>PMID: 30270488</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Animals ; Blood cells ; Bone marrow ; Carbon tetrachloride ; Cell Differentiation ; Cell migration ; Cell proliferation ; Cells (biology) ; Colonies ; Colony-stimulating factor ; Cytochrome P450 ; Cytochromes P450 ; Differentiation ; Fatty acid-binding protein ; Fibrosis ; Gene expression ; Growth factors ; Hematopoietic cells ; Hematopoietic Stem Cell Mobilization - methods ; Hemopoiesis ; Hepatic progenitor cells ; Hepatocytes ; Humans ; Leukocytes (granulocytic) ; Liver ; Liver Cirrhosis - genetics ; Liver Cirrhosis - therapy ; Liver diseases ; Liver fibrosis ; Liver Regeneration - genetics ; Male ; Mice ; Monocytes ; mRNA ; Opioid growth factor ; Opioid growth factor receptor‐like 1 ; Opioid receptors ; Organs ; Peripheral blood ; Progenitor cells ; Proteins ; Regeneration ; Regenerative Medicine - methods ; Regenerative therapy ; Spleen ; Stem cell transplantation ; Stem cells ; Stem Cells - metabolism ; Transfection</subject><ispartof>Stem cells (Dayton, Ohio), 2019-01, Vol.37 (1), p.89-101</ispartof><rights>AlphaMed Press 2018</rights><rights>AlphaMed Press 2018.</rights><rights>2019 AlphaMed Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4546-acdeb49cfcb1b551c018c2f78172d6e899c9d6fbfffaa63b3f3f5082c1577c7c3</citedby><cites>FETCH-LOGICAL-c4546-acdeb49cfcb1b551c018c2f78172d6e899c9d6fbfffaa63b3f3f5082c1577c7c3</cites><orcidid>0000-0001-6640-7688</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30270488$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yanagawa, Takayo</creatorcontrib><creatorcontrib>Sumiyoshi, Hideaki</creatorcontrib><creatorcontrib>Higashi, Kiyoshi</creatorcontrib><creatorcontrib>Nakao, Sachie</creatorcontrib><creatorcontrib>Higashiyama, Reiichi</creatorcontrib><creatorcontrib>Fukumitsu, Hiroshi</creatorcontrib><creatorcontrib>Minakawa, Kaori</creatorcontrib><creatorcontrib>Chiba, Yosuke</creatorcontrib><creatorcontrib>Suzuki, Yuhei</creatorcontrib><creatorcontrib>Sumida, Kayo</creatorcontrib><creatorcontrib>Saito, Koichi</creatorcontrib><creatorcontrib>Kamiya, Akihide</creatorcontrib><creatorcontrib>Inagaki, Yutaka</creatorcontrib><title>Identification of a Novel Bone Marrow Cell‐Derived Accelerator of Fibrotic Liver Regeneration Through Mobilization of Hepatic Progenitor Cells in Mice</title><title>Stem cells (Dayton, Ohio)</title><addtitle>Stem Cells</addtitle><description>Granulocyte colony stimulating factor (G‐CSF) has been reported to ameliorate impaired liver function in patients with advanced liver diseases through mobilization and proliferation of hepatic progenitor cells (HPCs). However, the underlying mechanisms remain unknown. We previously showed that G‐CSF treatment increased the number of bone marrow (BM)‐derived cells migrating to the fibrotic liver following repeated carbon tetrachloride (CCl4) injections into mice. In this study, we identified opioid growth factor receptor‐like 1 (OGFRL1) as a novel BM cell‐derived accelerator of fibrotic liver regeneration in response to G‐CSF treatment. Endogenous Ogfrl1 was highly expressed in the hematopoietic organs such as the BM and spleen, whereas the liver contained a relatively small amount of Ogfrl1 mRNA. Among the peripheral blood cells, monocytes were the major sources of OGFRL1. Endogenous Ogfrl1 expression in both the peripheral blood monocytes and the liver was decreased following repeated CCl4 injections. An intrasplenic injection of cells overexpressing OGFRL1 into CCl4‐treated fibrotic mice increased the number of HPC and stimulated proliferation of hepatic parenchymal cells after partial resection of the fibrotic liver. Furthermore, overexpression of OGFRL1 in cultured HPC accelerated their differentiation as estimated by increased expression of liver‐specific genes such as hepatocyte nuclear factor 4α, cytochrome P450, and fatty acid binding protein 1, although it did not affect the colony forming ability of HPC. These results indicate a critical role of OGFRL1 in the mobilization and differentiation of HPC in the fibrotic liver, and administration of OGFRL1‐expressing cells may serve as a potential regenerative therapy for advanced liver fibrosis. Stem Cells 2019;37:89–101
Intrasplenic administration of bone marrow mesenchymal stem cells (MSC) overexpressing opioid growth factor receptor‐like 1 into carbon tetrachloride (CCl4)‐induced fibrotic mice increased the number of α‐fetoprotein (AFP)‐positive cells with active bromodeoxyuridine (BrdU) uptake and that of proliferating parenchymal hepatocytes following 70% partial resection of the fibrotic liver.</description><subject>Animals</subject><subject>Blood cells</subject><subject>Bone marrow</subject><subject>Carbon tetrachloride</subject><subject>Cell Differentiation</subject><subject>Cell migration</subject><subject>Cell proliferation</subject><subject>Cells (biology)</subject><subject>Colonies</subject><subject>Colony-stimulating factor</subject><subject>Cytochrome P450</subject><subject>Cytochromes P450</subject><subject>Differentiation</subject><subject>Fatty acid-binding protein</subject><subject>Fibrosis</subject><subject>Gene expression</subject><subject>Growth factors</subject><subject>Hematopoietic cells</subject><subject>Hematopoietic Stem Cell Mobilization - methods</subject><subject>Hemopoiesis</subject><subject>Hepatic progenitor cells</subject><subject>Hepatocytes</subject><subject>Humans</subject><subject>Leukocytes (granulocytic)</subject><subject>Liver</subject><subject>Liver Cirrhosis - genetics</subject><subject>Liver Cirrhosis - therapy</subject><subject>Liver diseases</subject><subject>Liver fibrosis</subject><subject>Liver Regeneration - genetics</subject><subject>Male</subject><subject>Mice</subject><subject>Monocytes</subject><subject>mRNA</subject><subject>Opioid growth factor</subject><subject>Opioid growth factor receptor‐like 1</subject><subject>Opioid receptors</subject><subject>Organs</subject><subject>Peripheral blood</subject><subject>Progenitor cells</subject><subject>Proteins</subject><subject>Regeneration</subject><subject>Regenerative Medicine - methods</subject><subject>Regenerative therapy</subject><subject>Spleen</subject><subject>Stem cell transplantation</subject><subject>Stem cells</subject><subject>Stem Cells - metabolism</subject><subject>Transfection</subject><issn>1066-5099</issn><issn>1549-4918</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc9u1DAQhy1U1H_0wAsgS73QQ1rbiR37WJaWVtotCJZz5Djj1lU2XuykVTnxCBx5Pp4Eu1t6QOI0I80339j6IfSakmNKCDuJI6yOmaLiBdqlvFJFpajcSj0RouBEqR20F-MtIbTiUm6jnZKwmlRS7qJflx0Mo7PO6NH5AXuLNb7yd9Djd34AvNAh-Hs8g77__ePnewjuDjp8agz0EPToQ944d23wozN4nqYBf4ZrGPI0C5c3wU_XN3jhW9e7789XLmCt88qn4BPtsikfidgNeOEMvEIvre4jHDzVffT1_Gw5uyjmHz9czk7nhal4JQptOmgrZaxpacs5NYRKw2wtac06AVIpozphW2ut1qJsS1taTiQzlNe1qU25j95uvOvgv00Qx2blYvpdrwfwU2wYpZzVnFcsoYf_oLd-CkN6XaIElUIRLhN1tKFM8DEGsM06uJUODw0lTY6ryXE1Oa7EvnkyTu0Kumfybz4JONkA966Hh_-bmi_Ls8Wj8g9AKaK4</recordid><startdate>201901</startdate><enddate>201901</enddate><creator>Yanagawa, Takayo</creator><creator>Sumiyoshi, Hideaki</creator><creator>Higashi, Kiyoshi</creator><creator>Nakao, Sachie</creator><creator>Higashiyama, Reiichi</creator><creator>Fukumitsu, Hiroshi</creator><creator>Minakawa, Kaori</creator><creator>Chiba, Yosuke</creator><creator>Suzuki, Yuhei</creator><creator>Sumida, Kayo</creator><creator>Saito, Koichi</creator><creator>Kamiya, Akihide</creator><creator>Inagaki, Yutaka</creator><general>John Wiley & Sons, Inc</general><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-6640-7688</orcidid></search><sort><creationdate>201901</creationdate><title>Identification of a Novel Bone Marrow Cell‐Derived Accelerator of Fibrotic Liver Regeneration Through Mobilization of Hepatic Progenitor Cells in Mice</title><author>Yanagawa, Takayo ; Sumiyoshi, Hideaki ; Higashi, Kiyoshi ; Nakao, Sachie ; Higashiyama, Reiichi ; Fukumitsu, Hiroshi ; Minakawa, Kaori ; Chiba, Yosuke ; Suzuki, Yuhei ; Sumida, Kayo ; Saito, Koichi ; Kamiya, Akihide ; Inagaki, Yutaka</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4546-acdeb49cfcb1b551c018c2f78172d6e899c9d6fbfffaa63b3f3f5082c1577c7c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Blood cells</topic><topic>Bone marrow</topic><topic>Carbon tetrachloride</topic><topic>Cell Differentiation</topic><topic>Cell migration</topic><topic>Cell proliferation</topic><topic>Cells (biology)</topic><topic>Colonies</topic><topic>Colony-stimulating factor</topic><topic>Cytochrome P450</topic><topic>Cytochromes P450</topic><topic>Differentiation</topic><topic>Fatty acid-binding protein</topic><topic>Fibrosis</topic><topic>Gene expression</topic><topic>Growth factors</topic><topic>Hematopoietic cells</topic><topic>Hematopoietic Stem Cell Mobilization - methods</topic><topic>Hemopoiesis</topic><topic>Hepatic progenitor cells</topic><topic>Hepatocytes</topic><topic>Humans</topic><topic>Leukocytes (granulocytic)</topic><topic>Liver</topic><topic>Liver Cirrhosis - genetics</topic><topic>Liver Cirrhosis - therapy</topic><topic>Liver diseases</topic><topic>Liver fibrosis</topic><topic>Liver Regeneration - genetics</topic><topic>Male</topic><topic>Mice</topic><topic>Monocytes</topic><topic>mRNA</topic><topic>Opioid growth factor</topic><topic>Opioid growth factor receptor‐like 1</topic><topic>Opioid receptors</topic><topic>Organs</topic><topic>Peripheral blood</topic><topic>Progenitor cells</topic><topic>Proteins</topic><topic>Regeneration</topic><topic>Regenerative Medicine - methods</topic><topic>Regenerative therapy</topic><topic>Spleen</topic><topic>Stem cell transplantation</topic><topic>Stem cells</topic><topic>Stem Cells - metabolism</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yanagawa, Takayo</creatorcontrib><creatorcontrib>Sumiyoshi, Hideaki</creatorcontrib><creatorcontrib>Higashi, Kiyoshi</creatorcontrib><creatorcontrib>Nakao, Sachie</creatorcontrib><creatorcontrib>Higashiyama, Reiichi</creatorcontrib><creatorcontrib>Fukumitsu, Hiroshi</creatorcontrib><creatorcontrib>Minakawa, Kaori</creatorcontrib><creatorcontrib>Chiba, Yosuke</creatorcontrib><creatorcontrib>Suzuki, Yuhei</creatorcontrib><creatorcontrib>Sumida, Kayo</creatorcontrib><creatorcontrib>Saito, Koichi</creatorcontrib><creatorcontrib>Kamiya, Akihide</creatorcontrib><creatorcontrib>Inagaki, Yutaka</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Stem cells (Dayton, Ohio)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yanagawa, Takayo</au><au>Sumiyoshi, Hideaki</au><au>Higashi, Kiyoshi</au><au>Nakao, Sachie</au><au>Higashiyama, Reiichi</au><au>Fukumitsu, Hiroshi</au><au>Minakawa, Kaori</au><au>Chiba, Yosuke</au><au>Suzuki, Yuhei</au><au>Sumida, Kayo</au><au>Saito, Koichi</au><au>Kamiya, Akihide</au><au>Inagaki, Yutaka</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of a Novel Bone Marrow Cell‐Derived Accelerator of Fibrotic Liver Regeneration Through Mobilization of Hepatic Progenitor Cells in Mice</atitle><jtitle>Stem cells (Dayton, Ohio)</jtitle><addtitle>Stem Cells</addtitle><date>2019-01</date><risdate>2019</risdate><volume>37</volume><issue>1</issue><spage>89</spage><epage>101</epage><pages>89-101</pages><issn>1066-5099</issn><eissn>1549-4918</eissn><abstract>Granulocyte colony stimulating factor (G‐CSF) has been reported to ameliorate impaired liver function in patients with advanced liver diseases through mobilization and proliferation of hepatic progenitor cells (HPCs). However, the underlying mechanisms remain unknown. We previously showed that G‐CSF treatment increased the number of bone marrow (BM)‐derived cells migrating to the fibrotic liver following repeated carbon tetrachloride (CCl4) injections into mice. In this study, we identified opioid growth factor receptor‐like 1 (OGFRL1) as a novel BM cell‐derived accelerator of fibrotic liver regeneration in response to G‐CSF treatment. Endogenous Ogfrl1 was highly expressed in the hematopoietic organs such as the BM and spleen, whereas the liver contained a relatively small amount of Ogfrl1 mRNA. Among the peripheral blood cells, monocytes were the major sources of OGFRL1. Endogenous Ogfrl1 expression in both the peripheral blood monocytes and the liver was decreased following repeated CCl4 injections. An intrasplenic injection of cells overexpressing OGFRL1 into CCl4‐treated fibrotic mice increased the number of HPC and stimulated proliferation of hepatic parenchymal cells after partial resection of the fibrotic liver. Furthermore, overexpression of OGFRL1 in cultured HPC accelerated their differentiation as estimated by increased expression of liver‐specific genes such as hepatocyte nuclear factor 4α, cytochrome P450, and fatty acid binding protein 1, although it did not affect the colony forming ability of HPC. These results indicate a critical role of OGFRL1 in the mobilization and differentiation of HPC in the fibrotic liver, and administration of OGFRL1‐expressing cells may serve as a potential regenerative therapy for advanced liver fibrosis. Stem Cells 2019;37:89–101
Intrasplenic administration of bone marrow mesenchymal stem cells (MSC) overexpressing opioid growth factor receptor‐like 1 into carbon tetrachloride (CCl4)‐induced fibrotic mice increased the number of α‐fetoprotein (AFP)‐positive cells with active bromodeoxyuridine (BrdU) uptake and that of proliferating parenchymal hepatocytes following 70% partial resection of the fibrotic liver.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>30270488</pmid><doi>10.1002/stem.2916</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0001-6640-7688</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1066-5099 |
ispartof | Stem cells (Dayton, Ohio), 2019-01, Vol.37 (1), p.89-101 |
issn | 1066-5099 1549-4918 |
language | eng |
recordid | cdi_proquest_miscellaneous_2115275542 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
subjects | Animals Blood cells Bone marrow Carbon tetrachloride Cell Differentiation Cell migration Cell proliferation Cells (biology) Colonies Colony-stimulating factor Cytochrome P450 Cytochromes P450 Differentiation Fatty acid-binding protein Fibrosis Gene expression Growth factors Hematopoietic cells Hematopoietic Stem Cell Mobilization - methods Hemopoiesis Hepatic progenitor cells Hepatocytes Humans Leukocytes (granulocytic) Liver Liver Cirrhosis - genetics Liver Cirrhosis - therapy Liver diseases Liver fibrosis Liver Regeneration - genetics Male Mice Monocytes mRNA Opioid growth factor Opioid growth factor receptor‐like 1 Opioid receptors Organs Peripheral blood Progenitor cells Proteins Regeneration Regenerative Medicine - methods Regenerative therapy Spleen Stem cell transplantation Stem cells Stem Cells - metabolism Transfection |
title | Identification of a Novel Bone Marrow Cell‐Derived Accelerator of Fibrotic Liver Regeneration Through Mobilization of Hepatic Progenitor Cells in Mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T01%3A44%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20a%20Novel%20Bone%20Marrow%20Cell%E2%80%90Derived%20Accelerator%20of%20Fibrotic%20Liver%20Regeneration%20Through%20Mobilization%20of%20Hepatic%20Progenitor%20Cells%20in%20Mice&rft.jtitle=Stem%20cells%20(Dayton,%20Ohio)&rft.au=Yanagawa,%20Takayo&rft.date=2019-01&rft.volume=37&rft.issue=1&rft.spage=89&rft.epage=101&rft.pages=89-101&rft.issn=1066-5099&rft.eissn=1549-4918&rft_id=info:doi/10.1002/stem.2916&rft_dat=%3Cproquest_cross%3E2161869058%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2161869058&rft_id=info:pmid/30270488&rfr_iscdi=true |